The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...

Cyclobenzaprine is a generic drug that’s prescribed for muscle spasms. As with other drugs, cyclobenzaprine can cause side effects, such as drowsiness and anxiety. Cyclobenzaprine oral tablets are not ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A sublingual tablet form of the muscle ...

Please provide your email address to receive an email when new articles are posted on . Tonmya significantly reduced daily pain vs. placebo in a phase 3 trial in fibromyalgia. Fast track designation ...

Review the side-effects of Cyclobenzaprine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Details concerning the Cyclobenzaprine combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals), a first-in-class, nonopioid treatment for adults with fibromyalgia, a chronic pain syndrome that ...

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) ...

08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine ...

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...